BSR and BHPR guideline for the prescription and monitoring of non-biologic disease-modifying anti-rheumatic drugs

Source:
British Society for Rheumatology - BSR
Publisher:
British Society for Rheumatology (BSR)
Publication date:
27 February 2017

Abstract

The purpose of this guideline is to provide up-to-date, evidence-based recommendations for the safe use of non-biologic DMARDs in adults (>16 years old). The guideline is aimed at practitioners in both primary and secondary care settings. Specific areas that have been focused upon in this guideline include the following: recommendations regarding baseline screening prior to DMARD initiation; implications of co-morbid illness for DMARD prescribing; recommendations regarding monitoring for toxicity; management of DMARDs during intercurrent illness or surgery; and shared care guidelines.